K
Kite Pharma
Immune-based therapies to treat cancer indications
At a glance
- Status
- Listed
- Listing
- IPO 2014
News
Open roles
Kite Pharma in the Santa Monica ecosystem
The Kite Pharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- TRTwo River
- RSRiverbank Capital Securities
Lee Linden- APAlta Partners
Series B and later5 investors entered at this stage
- N(National Cancer Institute (NCI)
- ABArie Belldegrun
- WSWeizmann Institute of Science
- UCUniversity of California
- LALos Angeles
Source: Dealroom Talent Intelligence.
Patents
176 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Kite Pharma was the backer or acquirer, 2016–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
14 deals across Kite Pharma's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Kite Pharma's portfolio, mapped.
See Kite Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

